ENVERIC BIOSCIENCES, INC. (ENVB) Operating income 2016–2025
ENVERIC BIOSCIENCES, INC. (ENVB) annual operating income history from SEC filings — each fiscal year as reported.
-$8.8MFY2025 · since FY2016: -$5.4M → -$8.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.8M | +8.9% |
| FY2024 | -$9.6M | +41.4% |
| FY2023 | -$16.4M | +40.0% |
| FY2022 | -$27.4M | +57.6% |
| FY2021 | -$64.6M | -1050.4% |
| FY2020 | -$5.6M | -144.6% |
| FY2019 | -$2.3M | +67.9% |
| FY2018 | -$7.1M | +34.4% |
| FY2017 | -$10.9M | -102.5% |
| FY2016 | -$5.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENVB financial trends
ENVB RevenueENVB Net incomeENVB Net marginENVB Gross profitENVB Gross marginENVB Operating marginENVB Operating cash flowENVB Free cash flowENVB Capital expendituresENVB Return on equityENVB Stock buybacksENVB Dividends paidENVB Total assetsENVB Total liabilitiesENVB Shareholders’ equityENVB overview →